Classically, compartmentation of glutamate me tabolism in the brain is associated with the fact that neurons and glia exhibit distinct differences with regard to metabolism of this amino acid. The recent use of 13C-labeled compounds to study this metabolism in conjunction with the availability of cell type-specific tissue culture modes has led to the notion that such compartmentation may even be present in individual cell types, neurons as well as glia. To better understand and explain Metabolic pathways have classically been elucidated using radioactively labeled precursors, the metabolic fate of which may be followed by monitoring the appearance of radioactivity in the products. Alternatively, stable iso topes can be utilized. A specific radioacti vity of the prod uct remaining lower than that of the precursor would imply a simple product-precursor relationship, but when the specific radioactivity of the product rapidly exceeds that of the precursor, a compartmentation of the meta bolic pathway is likely to exist. Any organ with different cell types, each having a characteristic set of enzymes pertinent to the metabolic pathway in question, could potentially exhibit metabolic compartmentation. Early studies of glutamate metabolism in the brain (e.g., Clarke, 1969, 1983) clearly suggested compartmen tation since the product, glutamine, had much higher specific activity than its precursor, glutamate, after la beling with, e.g., [ 14 C]glucose. More recent studies of glutamate metabolism in either neurons or astrocytes AbbreviaTions used: GABA, "I-aminobotyric acid; TCA, tricarbox ylic acid.
this, it is proposed that mitochondrial heterogeneity may exist resulting in tricarboxylic acid cycles with different properties regarding cycling rates and ratio as well as coupling to amino acid biosynthesis, primarily involving glutamate and aspartate.
These hypotheses are evaluated in the light of current knowl edge about mitochondrial structure and function. Key Words:
Metabolic compartmentation-Mitochondria.
have suggested (e.g., Schousboe et aI., 1993) that the concept of metabolic compartmentation may be extended to apply even for individual cell types. To discuss this in detail, it will be necessary to evaluate the possibility of the existence of different types of mitochondria within the same cell. This so-called heteroplasmy is a well known phenomenon in patients with defects of the mi tochondrial genome (Taylor et aI., 1997) . The present review will discuss evidence for the existence of such intracellular mitochondrial heterogeneity in nonpatho logical brain cells. For a better comprehension of the biochemical differences, some background information will be given on mitochondrial location and ultrastruc ture.
Characterization of mitochondria was pioneered by Lehninger (1965) using mostly liver preparations as a model system. During the following 20 years, extensive work on mitochondrial characterization took place. For excellent reviews of this research on brain mitochondria, see Abood (1969) and Clark and Nicklas (1984) . The latter authors predicted an expansion in the area of mi tochondrial research related to aging and senile demen tia, and time has proven this prediction to be correct. Neurodegenerative disorders in general are characterized by a gradually progressing neuronal death, frequently accompanied by gliosis. A selective loss is taking place of defined groups of neurons that might be related either anatomically or physiologically. These diseases are ex emplified by Alzheimer's, Parkinson's, and Hunting-ton's diseases and cerebellar degenerations such as 01ivopontocerebellar atrophy. An increasing number of ob servations suggest that defects in energy metabolism are important pathophysiological mechanisms in neurode generative diseases (Plaitakis and Berl, 1988; Beal et aI., 1993) , although it is at present not possible to ascertain if the observed changes are secondary effects of neuronal loss and astrogliosis. In Parkinson's disease, a decrease in activity of complex I (NADH dehydrogenase, ubiqui none) of the mitochondrial energy metabolism has been implicated in the pathogenesis of the illness (Schapira et al., 1990) . Alzheimer's disease has been linked to reduc tion of pyruvate and 2-oxoglutarate dehydrogenase ac tivities, enzymes necessary for the tricarboxylic acid (TCA) cycle activity and thus oxidative production of NADH (Sheu et al., 1994; Heroux et al., 1996) . Central nervous system involvement has also been found in pa tients with mitochondrial myopathy. Hepatic encepha lopathy is a major neuropsychiatric complication of acute and chronic liver disease (Norenberg et al., 1992 ). An increased brain ammonia concentration, which is the result of liver cirrhosis, has been shown to lead to almost complete inhibition of 2-oxoglutarate dehydrogenase, a rate-limiting enzyme of the TCA cycle (Cooper and Plum, 1987) . The above-mentioned conditions lead ei ther to a decreased production of NADH, which in turn results in a decreased activity of complex I, or, as in . Parkinson's disease, to decreased activity of complex I directly (Schapira et aI., 1990) . It is well known that some neurons are more vulner able than others to different kinds of toxins, i.e., dopa minergic cells to I-methyl-4-phenyl-I,2,3,6-tetrahy dropyridine and certain areas of the hippocampus to lack of oxygen and increased extracellular glutamate concen trations. Thus, compartmentation of vulnerability involv ing mitochondria is well established. It is, however, also conceivable that sUbpopulations of mitochondria within the same cell could exhibit different degrees of vulner ability, but experimental evidence for this is at present still lacking.
MITOCHONDRIA

Mitochondrial location and ultrastructure
Mitochondria are distributed with varying densities throughout the CNS, with the more vascular parts con taining most mitochondria (Friede and Pax, 1961) . They are the cytoplasmic granules containing the enzymes in volved in oxidative metabolism. Since it is known that the brain is responsible for -25% of the total body oxy gen and glucose consumption, it must contain a high concentration of mitochondria. These have their greatest concentration in neurons (Abood, 1969) and are present throughout the perikaryon, cytoplasm, dendrites, axons, and nerve endings. Regions of particular abundance are nerve endings, the axon hillock, and nodes of Ranvier J Cereb Blood Flow Metah, Vol. 18. No. 3. 1998 (Abood, 1969) . They can be seen as rods (1 x 2.5 fLm) or rounded granules (4 fLm) in living neurons (McIlwain and Grinyer, 1950) . Mitochondrial heterogeneity has been demonstrated in the brain by separation of mito chondria of synaptic and peripheral origin, which showed slight differences in enzyme distribution (Lai et aI., 1977) . Mitochondria are found in oligodendroglia and Schwann cells, but they are not abundant in astro cytes and microglia.
Mitochondrial origin
Mitochondria originate by fission of preexisting mito chondria. In an evolutionary context, it should be noted that according to the endosymbiont hypothesis, the mi tochondria arose by internalization of bacteria by ancient eukaryotic celIs (De Duve, 1991; Margulis, 1993; Taylor et aI., 1997) . This hypothesis is at the present time broadly accepted and supported by a host of observa tions: The mitochondria have their own DNA, in the form of a circular piece of DNA that codes for a few endogenous proteins that are still synthesized by the or ganelle itself. The genetic code in the mitochondria shows distinct differences from the more universal code used by the nuclear DNA. The mitochondria replicate at times independently of their host cell in the cell cycle. The mqjority of the enzymes found in the mitochondria are, however, coded for by the genome in the host cell nucleus, produced by the host cell and subsequently transported to the mitochondria. Thus, all essential en zymes involved in the TCA cycle are synthesized by this mechanism.
METABOLIC COMPARTMENTA TION
Metabolic compartmentation in the brain has during the last three decades been studied extensively using ra dioactive substrates such as glucose, pyruvate, and lac tate, which label a large pool of glutamate or substrates such as acetate, 2-oxoglutarate, citrate, and bicarbonate, which label a smaIl pool of glutamate, which is further metabolized to glutamine (Berl and Clarke, 1969; Shank and Campbell, 1983; Hassel et aI., 1992) . Subsequent elucidation of the cellular localization of glutamine syn thetase in astrocytes (Norenberg and Martinez-Hernan dez, 1979) confirmed the originally proposed two-com partment model (Balazs et aI., 1972) for glutamate me tabolism with a small glial pool having a high turnover and a larger neuronal pool with a slow turnover.
As mentioned above, studies in the intact brain or in slices have shown that acetate metabolism takes place in the small glial compartment (Berl and Clarke, 1969; Badar-Goffer et aI., 1990; Hassel et aI., 1992) , a notion subsequently confirmed in cell culture studies using as trocytes (Sonnewald et aI., 1993c) . Cell culture tech niques have also demonstrated that glucose metabolism proceeds efficiently in both astrocytes and neurons (Son newald et aI., 1991 (Son newald et aI., , 1993c Peng et aI., 1994) . With [1-13 C]glucose as the substrate, glycolysis will produce labeled pyruvate with half of the molecules containing l3 C in the C-3 position. Through the action of pyruvate dehydrogenase, which is present in both astrocytes and neurons, acetyl CoA will enter the TCA cycle and sub sequently give rise to labeling predominantly in C-4 of glutamate, glutamine, and citrate and C-2 or C-3 in as partate. As the metabolites remain in the TCA cycle dur ing a second turn, there will also be labeling in C-2 and C-3 of glutamate, glutamine, and citrate. [2-IJ C]Acetate, which enters the TCA cycle after conversion to acetyl CoA by the mitochondrial enzyme acetyl CoA synthe tase, will give rise to the same labeling patterns in glu tamate, glutamine, and citrate as [1-I3 C]glucose (Fig. I) .
In contrast to neurons, astrocytes express pyruvate car boxylase, a mitochondrial ATP-dependent enzyme (Yu et aI., 1983; Shank et aI., 1985) . This will additionally allow entry of pyruvate into the TCA cycle by carbox ylation to [3-I3 C]oxaloacetate, which gives rise to label ing in C-2 of glutamate, glutamine, and citrate and in C-3 of aspartate ( Fig. I) .
Compartmentation of astrocyte metabolism
While compartmentation of glutamate metabolism in the brain has long been an accepted concept (Berl and Clarke, 1969) , such compartmentation within one cell type has only recently been reported. Mitochondrial het-
Lactate Pyruvate erogeneity within astrocytes was already 20 years ago suggested by Van den Berg et al. (1975) in an elegant review. More recent studies of metabolism of glutamate and glutamine in astrocytes have also suggested that such a compartmentation of glutamate metabolism may exist. It was shown that extracellular radioactive glutamine gave rise to a higher specific labeling of intracellular glutamate than glutamine and that aspmiate formation was dramatically different when exogenous glutamate or glutamine was used as the substrate in astrocytes (Schousboe et aI., 1993) . Compartmentation of malate metabolism has also been reported, as metabolism of malate at different concentrations was affected differ ently by certain metabolites and enzyme inhibitors (McKenna et aI., 1990) . By nuclear magnetic resonance analysis of I3 C incorporation into different positions in glutamine and citrate, information has been obtained that gives strong support to the concept of compartmentation of glutamate metabolism and hence of mitochondrial het erogeneity. Thus, using [2-I3 C]acetate together with un labeled glucose or [l-13 C]glucose together with unla beled acetate, it could be demonstrated that released glu tamine and citrate did not originate from the same TCA cycle in astrocytes (Sonnewald et aI., 1993a) .
With use of [U-13 C]glutamate as the major substrate, it was shown that astrocytes metabolize glutamate exten- (Sonnewald et aI., 1993b) . The labeling of lactate is particularly noteworthy since it indicated that lactate, which must be formed from pyruvate, can be produced from precursors derived from the TCA cycle (Sonnewald et aI., 1993b) . A similar conclusion has been reported by Bachelard et al. (1994) . Thus, citrate leaving the mitochondria may give rise to oxaloacetate in the cytoplasm and subsequently to pyruvate via the activity of cytosolic malic enzyme (McKenna et aI., 1990; Kurz et aI., 1993) or by the concerted action of phosphoenol pyruvate carboxy kinase and pyruvate kinase and then to lactate. Additionally, mitochondrial malic enzyme might be operative. The cystolic and mitochondrial pools of pyruvate did not mix freely as evidenced by the differ ential labeling of alanine and lactate. This is based on the fact that lactate dehydrogenase resides only in the cyto sol, while alanine aminotransferase is located both in the cytosol and in the mitochondria. Uniformly labeled lac tate but only mono labeled alanine was detected (Mc Kenna et aI., 1996; Sonnewald et aI., 1996) . Thus, uni formly labeled pyruvate was available in the cytosol for conversion by lactate dehydrogenase but not by alanine aminotransferase. The absence of uniformly labeled and the presence of monolabeled alanine indicated that this amino acid, in contrast to lactate, was derived from a TCA cycle that is associated with pyruvate carboxylation and/or a cycle in which 2-oxoglutarate remains for more than one turn, a strong indication of mitochondrial het erogeneity (Sonnewald et aI., 1996) .
Compartmentation of neuronal metabolism
Indications that neuronal mitochondrial metabolism of glutamate may be compartmentalized, suggesting mito chondrial heterogeneity, have come from studies of me tabolism of l3 C-Iabeled glutamate, glutamine, and lactate in cultured cerebral cortical neurons, the vast majority of which are GABAergic (Yu et aI., 1984; Drejer et aI., 1987) . These neurons metabolized [U-13 C]glutamate ex tensively, with label appearing predominantly in aspar tate and 'Y-aminobutyric acid (GABA) (Westergaard et ai., 1995) . Label from [U-I3 C]glutamine appeared in the same molecules but with different labeling ratios. Label incorporation into GABA after 3 hours was similar from glutamate and glutamine, 13 and 15%, respectively, im plicating the existence of a large unlabeled GABA pool, due either to a slow turnover of GABA in cell cultures or the preference of synthesis from other precursors (West ergaard et aI., 1995) . Even though incorporation of label was similar from the two precursors, the labeling patterns were different. Approximately 50% of GABA formed from labeled glutamine was derived from the TCA cycle, whereas only 30% of GABA formed from glutamate J Cereb Blood Flow Metab, Vol, 18, No, 3, 1998 originated from this cycle (Westergaard et aI., 1995) . TCA cycle involvement in the synthesis of GABA, as partate, glutamate, and glutamine could be determined by analysis of doublets present in the nuclear magnetic resonance spectra. The J3 C enrichment in aspartate was almost twice as high from glutamate (37%) as from glu tamine (20%). In addition, aspartate was more highly labeled than GABA. When glutamine was the precursor, aspartate was also more highly labeled than glutamate (Westergaard et aI., 1995) . Also, in the intact brain, there is evidence to suggest that synthesis of GABA from glu tamine and glutamate may be complex. Thus, enrichment of J3 C in analogous C atoms in these amino acids after infusion of rabbits with [U-13 C]glucose showed the same values for glutamate and GAB A, while that in glutamine was different (Lapidot and Gopher, 1994) .
When cerebral cortical neurons were incubated for 4 hours with [U-!3 C]lactate, an extensive incorporation of J3 C into the cellular pool of the amino acids aspartate, glutamate, and GABA was observed, although net syn thesis of these amino acids from lactate is not possible. This finding suggests that lactate is metabolized in a TCA cycle that also gives rise to aspartate, glutamate, and GABA. A reduction of enrichment in 13 C atoms was seen in aspartate and glutamate but not in GABA when nonlabeled glutamine was added to the incubation me dium, suggesting the existence of at least two glutamate pools, of which one serves as a precursor for the synthe sis of GABA and the other for synthesis of aspartate. A decrease in cycling ratios for the TCA cycle precursors, in the presence of glutamine, points in the same direc tion, since cycling for the TCA cycle constituents serving as precursors for GABA decreased more than the corre sponding cycling for glutamate and aspartate precursors. It could be argued that the presence of a small number of astrocytes in the neuronal cultures (Larsson et aI., 1985) could contribute to the difference in glutamate/aspartate and GABA labeling. It should, however, be noted that glutamine was only marginally labeled (U. Sonnewald, unpublished data) and that astrocytes utilize lactate poorly compared with neurons (H. S. Waagepetersen et aI., submitted) .
Surprisingly, alanine did not exhibit labeling from [U-I3 C]lactate in cerebral cortical neurons. Since the equilibrium constant for the alanine aminotransferase re action is close to unity (Krebs, 1953) , this observation is most likely explained by compartmentation of pyruvate metabolism or by rapid formation of mitochondrial ace tyl CoA from pyruvate (Fitzpatrick et aI., 1988) . Since alanine is labeled in astrocytes under these conditions (Sonnewald et aI., 1991) , this is a further indication that the presence of a small number of astrocytes in the cul tures could not explain the differential labeling patterns in glutamate/aspartate and GABA.
These results are best explained postulating that lac-tate enters at least two TCA cycles (Fig. 2) . In the ab sence of added glutamine, one TCA cycle, which has a rapid turnover, is in exchange with the aspartate pool and one glutamate pool. The other cycle in which interme diates stay for only a few turns is in contact with the GABA pool. Glutamine added exogenously gains access to the aspartate-forming TCA cycle as indicated by an increase in the aspartate concentration (Waagepetersen et a!., 1998) but has no direct access to the TCA cycle from which intermediates serve as precursors for GAB A syn thesis (Fig. 2) . The model suggests that aspartate flows between the two TCA cycles located in different mito chondria, but it should be noted that other C-4 units such as malate could substitute for aspartate.
MITOCHONDRIAL HETEROGENEITY
Involvement in metabolic compartmentation
Biochemical (Gallo et a!., 1987) , physiological (Trim mer et aI., 1986), and developmental (Raff, 1989 ) het erogeneity of mitochondria has been described in the literature. Although heterogeneity of cell cultures is pos sible, a growing amount of evidence seems to point strongly toward intracellular compartmentation of me tabolism in individual cells as well. In the following paragraphs, some models are presented that may explain such compartmentation.
Intercellular heterogeneity in astrocytes has been shown by Oh et aI. (1991) by visualizing oxidative me tabolism in cultured glial cells by indirect fluorescence labeling of mitochondrial malate dehydrogenase. In pro cess-bearing astrocytes and oligodendroglia, mitochon drial malate dehydrogenase was reported to be uniformly distributed, whereas in polygonal astrocytes that con tained relatively similar numbers of mitochondria, im munoreactivity to mitochondrial malate dehydrogenase varied among cells from very weakly positive to in tensely positive.
Several possibilities exist for cellular compartmenta tion of the TCA cycle metabolism. There could be dif-ferent types of mitochondria within the same cell, or different TCA cycles might be operative and separated within the same mitochondrion. Support for the latter notion is obtained from a nuclear magnetic resonance study of mitochondrial viscosity by Lopez-Beltran et aI. (1996) , which showed that free diffusion of metabolites within mitochondria is unlikely.
Heterogeneous microenvironments are also indicated by the observations of Jones (1986) , who reported that mitochondria appeared to be clustered in sites of high A TP demand and concl uded: "Thus, micro heterogeneity of metabolite concentrations can occur in cells without membranal compartmentation and may be important in determining the rates of various high flux processes."
Origin of mitochondrial heterogeneity
The observations mentioned above may be interpreted in favor of the existence of at least two compartments with differently functioning TCA cycles. This is unlikely to be caused by two genetically discrete types of mito chondria in the same cell. The mitochondrial genome has been completely mapped and is of a very small size. More likely, therefore, this compartmentation is a con sequence of the development of distinctly different en vironments for mitochondria in astrocytes and neurons. Differential transport of proteins coded for by the cell nucleus to the different mitochondria will result in dif ferent environments and thereby facilitate modulation of basic mitochondrial functions. Several reports on differ ential transport of mRNA within neurons might support this view. Thus, Landry et al. (1994) observed that mRNA encoding glutamate decarboxylase-67, an en zyme associated with membranes (Dirkx et aI., 1995) , was confined to cell somas. Furthermore, Chun et aI. (1996) reported differential transport of mRNA species into axonal domains of the squid giant axon. One has to bear in mind, however, that relative abundance of mRNA not always correlates with the amount of the correspond ing proteins.
Mitochondrial heterogeneity in neurons would appear to be the rule sooner than the exception since these cells are highly polar, being composed of dendrites, cell bod ies, and axons, i.e., compartments with widely differing needs. Because of the lack of the machinery for protein synthesis in axons, materials required in axons and syn apses have to be transported down the axon after syn thesis in the cell body. Furthermore, fast anterograde transport conveys mitochondria to their destinations (Kondo et al., 1994) . It is not known if such mitochon dria contain a complete set of enzymes already from the start or, as appears more likely, collect the enzymes re quired for the type of work that needs to be carried out at their destination.
